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Abstract
Background: The COVID-19 pandemic has placed significant pressure on health and social care. Survivors of
COVID-19 may be left with substantial functional deficits requiring ongoing care. We aimed to determine whether
pre-admission frailty was associated with increased care needs at discharge for patients admitted to hospital with
COVID-19.
Methods: Patients were included if aged over 18 years old and admitted to hospital with COVID-19 between 27
February and 10 June 2020. The Clinical Frailty Scale (CFS) was used to assess pre-admission frailty status. Admission
and discharge care levels were recorded. Data were analysed using a mixed-effects logistic regression adjusted for
age, sex, smoking status, comorbidities, and admission CRP as a marker of severity of disease.
Results: Thirteen hospitals included patients: 1671 patients were screened, and 840 were excluded including, 521
patients who died before discharge (31.1%). Of the 831 patients who were discharged, the median age was 71
years (IQR, 58–81 years) and 369 (44.4%) were women. The median length of hospital stay was 12 days (IQR 6–24).
Using the CFS, 438 (47.0%) were living with frailty (≥ CFS 5), and 193 (23.2%) required an increase in the level of
care provided. Multivariable analysis showed that frailty was associated with an increase in care needs compared to
patients without frailty (CFS 1–3). The adjusted odds ratios (aOR) were as follows: CFS 4, 1.99 (0.97–4.11); CFS 5, 3.77
(1.94–7.32); CFS 6, 4.04 (2.09–7.82); CFS 7, 2.16 (1.12–4.20); and CFS 8, 3.19 (1.06–9.56).
Conclusions: Around a quarter of patients admitted with COVID-19 had increased care needs at discharge. Pre-
admission frailty was strongly associated with the need for an increased level of care at discharge. Our results have
implications for service planning and public health policy as well as a person's functional outcome, suggesting that
frailty screening should be utilised for predictive modelling and early individualised discharge planning.
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Background
COVID-19 has resulted in large numbers of people be-
ing admitted to hospital worldwide [1–3]. The UK gov-
ernment guidance published on 25 August 2020
estimates that 95% of patients admitted with COVID-19
may be discharged home, but 50% would require volun-
tary and community support and 45% health and social
care services, and 4% would be discharged to rehabilita-
tion and 1% into long-term care facilities [4]. However,
these figures do not take into account those that already
have these services in place pre-admission. Patients may
experience functional deterioration requiring temporary
or permanent support from community social care and
rehabilitation services on discharge from hospital [5–7].
A proportion of this group may require a change in liv-
ing situation, for example, a long-term care facility such
as residential or nursing home.
People at higher risk of requiring hospital admission
due to COVID-19 are older with greater levels of multi-
morbidity and frailty [8, 9]. Frailty represents increased
vulnerability to stressors due to declined physiological
systems and loss of homeostasis [10, 11]. In a wide range
of conditions, even after adjusting for age and comorbid-
ity, frailty has been reported as an independent predictor
of mortality, prolonged hospital stay, and increased care
needs following hospital discharge [12, 13]. Similar ef-
fects due to COVID-19 have been reported including
mortality and increased length of hospital stay [9].
To date, most studies in older people with COVID-
19 have focussed on mortality with little attention to
functional outcomes. However, in older adults, mor-
tality is not always the most important outcome. Pre-
vious studies assessing the impact of frailty on quality
of life in other conditions have demonstrated that for
older adults, independent living is a more important
outcome than death. A higher value is placed on con-
tinuing day-to-day societal roles, reducing the risk of
isolation and loneliness and avoiding poor future
health outcomes [14–16]. Currently, there is no litera-
ture describing the factors associated with a loss of
independence, or associated increase in care needs,
after hospital admission post-acute COVID-19. The
aim of this study was to investigate the association
between pre-admission frailty and change in the level




Data were obtained as part of a multicentre observa-
tional study: COPE (COVID-19 in Older People study).
The study was authorised by the Health Research Au-
thority (20/HRA/1898) in the UK and the Ethics Com-
mittee of Policlinico Hospital Modena (Reference 369/
2020/OSS/AOUMO) in Italy. The full study details can
be found within the COPE protocol [17], and the main
study findings are reported elsewhere [9]. This manu-
script follows the STROBE statement for reporting of
cohort studies. Investigators carried out standardisation
training in both data collection and CFS assessment. A
central MACRO database, hosted by King’s Clinical Tri-
als Unit (KCTU), was used to enter data centrally.
Setting
The COPE-Discharge study used an established network
of twelve UK sites and one Italian site. The UK centres
included Ysbyty Ystrad Fawr in Caerphilly, Royal Gwent
Hospital in Newport, Nevill Hall Hospital in Aberga-
venny, University Hospital of Wales in Cardiff, South-
mead Hospital in Bristol, Aberdeen Royal Infirmary,
Royal Alexandra Hospital in Paisley, Inverclyde Royal
Hospital, Salford Royal Hospital, Glasgow Royal Infirm-
ary, Maidstone Hospital, and Ysbyty Gwynedd in Ban-
gor. The Italian centre was the University Hospital of
Modena Policlinico.
Participants
Each site research team screened hospital admission lists
daily. The ethical approval was such that formal written
consent from participants was deemed as not being re-
quired as all data were routinely collected in hospital
records.
Inclusion/exclusion criteria
The study included consecutive hospitalised patients
aged 18 years or older with a confirmed diagnosis of
COVID-19 admitted between 27 February and 10 June
2020; diagnostic criteria included laboratory-confirmed
SARS-CoV-2-positive swab or a clinical diagnosis of
COVID-19 based on signs, symptoms, and supporting
radiology. Patients were excluded due to missing care
level at admission and discharge, were not discharged
from hospital, and that died prior to discharge.
Outcome
The primary outcome was increased care needs at dis-
charge. Care was recorded as an ordinal variable, with
seven levels of increasing dependence care needs: at
home without formal carers, own home with carers (for-
mal or informal), intermediate care, increased number of
daily carer visits, sheltered care, residential home, and
nursing home.
The number of daily carer visits required by patients
was measured at admission and discharge. Sheltered care
was the accommodation of private independent units
with shared facilities such as gardens and lounges and a
warden on site. Residential care was defined as 24-h sup-
ported care managed by non-nursing trained care staff.
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Nursing care comprised service users receiving 24-h
support from nursing staff, requiring assistance with
most personal daily activities, or support with complex
physical and/or psychological needs. Intermediate care
varied depending on local provision and was defined as
short-term care (either in an institution or individual’s
home) designed to facilitate the transition from hospital
to home [18, 19]. Intermediate care services develop
person-centred goals aimed at optimising independence
and well-being of individuals through collaborative
multidisciplinary holistic assessment and interventions.
Covariates
Demographic and clinical characteristics recorded at ad-
mission were age, sex, smoking status (never, previous,
or current), C-reactive protein (CRP) as a marker of dis-
ease severity, estimated glomerular filtration rate (eGFR),
previous history of coronary artery disease (CAD), dia-
betes mellitus, chronic obstructive pulmonary disease
(COPD), and hypertension (no, yes not on treatment,
and yes on treatment).
Frailty was scored based on a functional status history
from 2 weeks prior to admission and was measured
using the Clinical Frailty Scale (CFS). The CFS is a 9-
point score, from 1 being very fit, 2 well, 3 managing
well, 4 living with very mild frailty, 5 living with mild
frailty, 6 living with moderate frailty, 7 living with severe
frailty, 8 living with very severe frailty, and 9 terminally
ill but otherwise living with severe frailty [13]. For the
purpose of the analyses, CFS categories 1–3 were
grouped and used as a reference group. In each site, the
assessment of CFS in patients was undertaken by clinical
teams comprising a combination of consultant geriatri-
cians, emergency physicians, and intensive care consul-
tants. For all COVID-19 patients admitted to hospital,
the CFS was documented in a dedicated section on the
admission notes. To safeguard data quality, each princi-
pal investigator ensured adequate knowledge within the
data collection team of frailty scoring.
Statistical analysis
We analysed the change in care level using a mixed-
effects logistic regression, fitted with a random effect
model to account for variation occurring at each hospital
site. Care level was associated with baseline frailty and
adjusted for patient age group (< 65, 65–79, ≥ 80 years
old), sex, smoking status (never smoker, ex-smoker,
current smoker), CRP (≥ 40mg/L taken as abnormal),
diabetes (no/yes), hypertension (no/yes/yes and on treat-
ment), coronary artery disease (no/yes), and reduced
renal function (eGFR < 60, ≥ 60 mL/min/1.73 m2). Both
crude odds ratios (OR) and adjusted odds ratios (aOR)
were calculated with 95% confidence intervals (95% CI).
The analysis was carried out using Stata version 15.
We carried out a sensitivity analysis to assess longer-
term increased dependence by excluding patients that
were discharged with intermediate care.
Results
As per the CONSORT flow diagram (Fig. 1), a total of
1671 patient records were entered into the COPE-
Discharge database from 13 sites. Eight hundred and
forty patients (840) were excluded: 112 patients due to
missing care level at admission and discharge, 202 pa-
tients due to being alive still in hospital, and 526 had
died in hospital.
Of the 831 patients meeting the inclusion criteria
(Table 1), the median patient age was 71 years (58–81
[IQR], range 19 to 100) and 369 (44.4%) were women.
The median length of hospital stay was 12 days (6–24
[IQR], 0–145 [min–max]), and 388 (46.7%) patients were
considered to be living with frailty (CFS 5 to 9). Of the
included patients, 30 (3.6%) were under 65 years old and
had an increased level of care. Of the 30 patients, 9 went
from living independently at admission to requiring a
carer, and 13 required intermediate care. There were 36
patients with a missing care level at discharge imputed
as not experiencing an increased care.
Before hospital admission, 596 patients (71.7%) lived
independently at home without a carer and a further 74
(8.9%) lived at home with carer support. The remaining
19.1% were living in either a sheltered, residential, or
nursing care setting (Table 2). Across the 13 sites, 193
(23.2%) patients were discharged with an increase in care
level compared with that documented on admission.
Fewer patients under 65 years old (30 out of 315, 9.5%)
required an increase in care level compared with those
of aged 80 years or older (87/242, 35.9%).
As shown in Table 2, of the 596 patients who were liv-
ing at home without formal care before admission, 143
(24.0%) required an increased level of care at discharge.
Of the 74 patients who were living at home with carers
before admission, 17 (23.0%) required an increased level
of care. Of the 158 patients who came from a sheltered
accommodation, residential, or nursing home, 30
(19.0%) required an increased level of care. An increased
care level occurred in 10.2%, 12.6%, and 13.1% for the
least frail categories of CFS 1, 2, and 3, respectively
(Table 1). This compared to the following: CFS 4, 20.0%;
CFS 5, 36.9%; CFS 6, 38.5%; CFS 7, 26.1%; and CFS 8,
36.4%.
In the crude logistic regression analysis, CFS was asso-
ciated with an increase in care at discharge (Table 3).
Compared to CFS 1–3, CFS 4 OR = 2.71 (95% CI 1.38–
5.34, p = 0.004), CFS 5 OR = 5.63 (95% CI 3.08–10.27,
p < 0.0001), CFS 6 OR = 5.90 (95% CI 3.24–10.75, p <
0.0001), CFS 7 OR = 3.50 (95% CI 1.90–6.47, p < 0.0001),
and CFS 8 OR = 4.30 (95%CI 1.53–12.09, p = 0.006). The
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covariates associated with an increased level of care at
discharge were age (compared to < 65 years: 65–79 OR =
3.71 (95% CI 2.18–6.30, p < 0.0001); ≥ 80 OR = 5.79
(95% CI 3.35–9.98, p < 0.0001)) and elevated CRP (≥ 40
mg/L) OR = 0.65 (95% CI 0.45–0.94, p = 0.022).
Of the 831 included participants, 810 (97.5%) exhibited
complete data and were included in the mixed-effects
multivariable logistic regression analysis. After adjust-
ment for the other comorbidities and CRP on admission,
an increase in the level of care at discharge was associ-
ated with frailty. Compared to CFS 1–3, CFS 4 aOR =
1.99 (95% CI 0.97–4.11, p = 0.062), CFS 5 aOR = 3.77
(95% CI 1.94–7.32, p = 0.0001), CFS 6 aOR = 4.04 (95%
CI 2.09–7.82, p < 0.0001), CFS 7 aOR = 2.16 (95% CI
1.12–4.20, p = 0.022), and CFS 8 aOR = 3.19 (95% CI
1.06–9.56, p = 0.039). Other covariates associated with
an increased level of care were age (compared to < 65
years: 65–79 aOR = 2.82 (95% CI 1.57–5.06, p = 0.0005);
> 80 aOR = 3.87 (95% CI 2.07–7.26, p < 0.0001)) and
CAD (aOR = 0.49, 95% CI 0.29–0.82, p = 0.007).
A sensitivity analysis carried out that only included pa-
tients that received a longer-term increase in care (by re-
moving intermediate care) at discharge found frailty was
associated with an increased care needs, compared to
CFS 1–3.
Discussion
Our study has demonstrated that pre-admission frailty
status is associated with a person’s level of independence
after discharge from hospital following admission with
COVID-19. Although many patients had no formal care
prior to admission, almost a quarter acquired COVID-
19-related functional dependence exhibited by additional
care required on discharge. These findings are in keep-
ing with other studies demonstrating worse functional
outcomes associated with greater pre-hospital levels of
frailty [20].
Although not synonymous with advancing age, frailty
is more prevalent in the older population, and as a con-
sequence, older people are more likely to require care.
These data have shown that risk of increased care needs
following hospitalisation with COVID-19 is also associ-
ated with increasing age, with those over 80 years or
older significantly more likely to require increased care
at discharge than younger people.
The association of frailty and age with increased func-
tional dependence on discharge can be used to assist
with early identification, at the point of hospital admis-
sion, of people at risk of needing more care. These data
can aid clinicians in providing early tailored assessments
and management plans to patients. One paradigm of this
tailored assessment is a comprehensive geriatric assess-
ment (CGA) effected through geriatric medicine clini-
cians in conjunction with the multidisciplinary team.
CGA produces a personalised and integrated manage-
ment plan using a multimodal, multimorbidity, and
multidisciplinary approach over time. It has been shown
to reduce post-acute long-term functional dependence
and mortality [21–23]. Ensuring CGA-trained clinicians
are embedded in acute hospital pathways will allow early
screening of vulnerable patients and the potential chance
to modify post-COVID outcomes.
These data may be unique to hospital admissions dur-
ing the pandemic and not pertain to non-COVID times.
Hospital-based teams are being faced with unique chal-
lenges: streamlined discharge processes aimed at main-
taining capacity within the acute setting, reduced access
to specialist inpatient therapy resources due to high ser-
vice demand, sickness-related staff absences, and the
breakdown of pre-pandemic informal care arrangements
due to social distancing restrictions [4]. It is difficult to
interpret if these data reflect the Department of Health’s
estimate that 50% of patients would be able to be dis-
charged home without care—50.7% in this cohort
Fig. 1 CONSORT flow diagram
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Table 1 Patient characteristics, by increased level of care at discharge following hospital admission of adult patients hospitalised
with COVID-19
Care level at discharge (compared to admission) Total
The same level of care at discharge An increased level of care at discharge
Sites (n = 638) (n = 193) (n = 831)
Hospital A 58 (56.3) 45 (43.7) 103 (12.4)
Hospital B 73 (77.7) 21 (22.3) 94 (11.3)
Hospital C 32 (100) 0 (0) 32 (3.9)
Hospital D 47 (61.8) 29 (38.2) 76 (9.1)
Hospital E 14 (28.6) 35 (71.4) 49 (5.9)
Hospital F 183 (86.7) 28 (13.3) 211 (25.4)
Hospital G 17 (94.4) 1 (5.6) 18 (2.2)
Hospital H 85 (88.5) 11 (11.5) 96 (11.6)
Hospital I 79 (87.8) 11 (12.2) 90 (10.8)
Hospital J 17 (68.0) 8 (32.0) 25 (3.0)
Hospital K 6 (75.0) 2 (25.0) 8 (1.0)
Hospital L 14 (100) 0 (0) 14 (1.7)
Hospital M 13 (86.7) 2 (13.3) 15 (1.8)
Age
Under 65 years 285 (90.5) 30 (9.5) 315 (37.9)
65 to 79 years 198 (72.3) 76 (27.7) 274 (33.0)
80 years or older 155 (64.0) 87 (36.0) 242 (29.1)
Sex
Female 280 (75.9) 89 (24.1) 369 (44.4)
Male 357 (77.4) 104 (22.6) 461 (55.5)
Missing 1 0 1
Smoking status
Never smokers 346 (76.5) 106 (23.4) 452 (54.4)
Ex-smokers 226 (75.3) 74 (24.7) 300 (36.1)
Current smokers 49 (80.3) 12 (19.7) 61 (7.3)
Missing 17 1 18
Diabetes
No 481 (77.0) 144 (23.0) 625 (75.2)
Yes 156 (76.1) 49 (23.9) 205 (24.7)
Missing 1 0 1
Hypertension
No 341 (78.8) 92 (21.2) 433 (52.1)
Yes (not on treatment) 70 (82.4) 15 (17.6) 164 (10.2)
Yes (on treatment) 227 (72.5) 86 (27.5) 313 (37.7)
Coronary artery disease
No 521 (76.3) 162 (23.7) 683 (82.2)
Yes 117 (79.1) 31 (20.9) 148 (17.8)
Elevated CRP (≥ 40)
No 205 (71.2) 83 (28.8) 288 (34.7)
Yes 433 (79.7) 110 (20.3) 543 (65.3)
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returned to their own home with no support, but this
figure excludes the 19% in this study admitted from
sheltered accommodation or a care home—and whether
the Department of Health estimate includes these
groups [4]. Furthermore, these findings have implica-
tions for both health and social care funding with a large
economic package required to provide adequate support
for a more dependent population post COVID-19. Local
providers can use these data to anticipate short-term
budgets based on the frailty statuses of the hospitalised
population. Future research should focus on the trajec-
tory of patients' COVID-19-acquired functional depend-
ence, as well as examine population-based frailty scoring
with the same associations of an increased level of care,
Table 1 Patient characteristics, by increased level of care at discharge following hospital admission of adult patients hospitalised
with COVID-19 (Continued)
Care level at discharge (compared to admission) Total
The same level of care at discharge An increased level of care at discharge
Renal function (eGFR < 60)
No 440 (77.5) 128 (22.5) 568 (68.4)
Yes 180 (73.5) 65 (26.5) 245 (29.5)
Missing 18 0 18
Care level at admission
House/flat (no carer) 452 (75.8) 144 (24.2) 596 (71.7)
House/flat (with carer) 58 (78.4) 16 (21.6) 74 (8.9)
Sheltered care 27 (73.0) 10 (27.0) 37 (4.5)
Residential care 48 (85.7) 8 (14.3) 56 (6.7)
Nursing care 53 (81.5) 12 (18.5) 65 (7.8)
Missing 0 3 3
Clinical Frailty Scale (CFS)
1, Very fit 53 (89.8) 6 (10.2) 59 (7.1)
2, Fit 104 (87.4) 15 (12.6) 119 (14.3)
3, Managing well 139 (86.9) 21 (13.1) 160 (19.3)
4, Vulnerable 80 (80.0) 20 (20.0) 100 (12.0)
5, Mildly frail 70 (63.1) 41 (36.9) 111 (13.4)
6, Moderately frail 72 (61.5) 45 (38.5) 117 (14.1)
7, Severely frail 99 (73.9) 35 (26.1) 134 (16.1)
8, Very severely frail 14 (63.6) 8 (36.4) 22 (2.6)
9, Terminally ill 3 (75.0) 1 (25.0) 4 (0.5)
Missing 4 1 5
Table 2 Care level at admission (rows) versus discharge care status (column) of adult patients hospitalised with COVID-19
















Care level on admission
Missing 3* 3
Own home 31 422 39* 1* 20* 19* 12* 52* 596
Own home (with carer
visits)
9 48 11* 6* 74
Sheltered care 1 2 24 3* 7* 37
Residential care 2 1 45 6* 2* 56
Nursing care 2 1 1 49 12* 65
Total 36 433 88 26 66 74 26 82 831
*Data in bold indicate patients that were recorded as having increased care at discharge
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in order to improve the regional and national social care
predicted spend [4].
To minimise the personal and societal burden of
COVID-19-related functional decline and increased care
needs, urgent strategies are required: firstly, avoiding
transmission of the virus through public health tech-
niques such as contact tracing, infection control mea-
sures, and social distancing including shielding;
secondly, modification of frailty pre-admission may
ameliorate the risk of post-acute deterioration [24–28];
thirdly, post-acute rehabilitation through specialist
multidisciplinary rehabilitation services needs to be tar-
geted at those who have been affected to promote a re-
turn to pre-admission function [29–31].
Strengths and limitations
This is a multicentre study with a large sample size re-
ceiving real-world care. Data were collected and curated
by clinicians with an interest in older adults and pro-
cesses aimed at maximising data completion and
decreasing bias. Baseline patient characteristics and clin-
ical outcomes demonstrated are in line with other
COVID-19 publications suggesting external validity, for
example, almost three quarters of patients in this cohort
were 65 years of age or older consistent with published
evidence [1–3].
This study had several limitations: data to be cautious
include the inter-hospital consistency of the services de-
livered within the term intermediate care; the difference
between crude and adjusted effect of CAD; and the use
of the CSF in people of all ages as this tool has been pri-
marily validated in populations over 65 years. This study
describes an increased care level at the time of hospital
discharge but not beyond that time.
Conclusions
Frailty is associated with an increased level of care post
hospital admission with COVID-19. In this study, 23.2%
of discharged patients required an increased care level
on discharge. This study suggests that future public
Table 3 Increased care at discharge of patients hospitalised with COVID-19
Crude odds ratio (OR) Adjusted OR (aOR)& (n = 810)&&
OR (95%CI) p value aOR (95%CI) p value
Age
Under 65 Reference Category Reference Category
65 to 79 3.71 (2.18–6.30) < 0.0001 2.82 (1.57–5.06) 0.0005
≥ 80 5.79 (3.35–9.98) < 0.0001 3.87 (2.07–7.26) < 0.0001
Sex (female) Reference Category Reference Category
Male 0.98 (0.68–1.40) 0.91 1.20 (0.81–1.79) 0.37
Smoking status (never) Reference Category Reference Category
Ex-smokers 1.38 (0.95–2.02) 0.09 1.08 (0.71–1.63) 0.73
Current smokers 0.92 (0.45–1.90) 0.83 1.05 (0.47–2.33) 0.90
Elevated CRP (≥ 40) 0.65 (0.45–0.94) 0.022 0.73 (0.49–1.09) 0.12
Patients with diabetes 1.12 (0.75–1.69) 0.57 0.99 (0.63–1.55) 0.97
Patients with CAD 0.82 (0.51–1.31) 0.41 0.49 (0.29–0.82) 0.007
Patients with hypertension
Yes (not on treatment) 0.82 (0.43–1.59) 0.56 0.65 (0.32–1.32) 0.23
Yes and on treatment 1.12 (0.77–1.63) 0.57 0.98 (0.64–1.50) 0.94
Patients with reduced renal function (eGFR < 60) 1.39 (0.95–2.03) 0.09 1.03 (0.67–1.58) 0.90
Clinical Frailty Scale (CFS 1 to 3) Reference Category Reference Category
CFS 4 2.71 (1.38–5.34) 0.004 1.99 (0.97–4.11) 0.062
CFS 5 5.63 (3.08–10.27) < 0.0001 3.77 (1.94–7.32) 0.0001
CFS 6 5.90 (3.24–10.75) < 0.0001 4.04 (2.09–7.82) < 0.0001
CFS 7 3.50 (1.90–6.47) < 0.0001 2.16 (1.12–4.20) 0.022
CFS 8 4.30 (1.53–12.09) 0.006 3.19 (1.06–9.56) 0.039
CFS 9&&&
&The multivariable mixed-effects logistic regression was adjusted for age group, sex, smoking, CRP, diabetes, CAD, hypertension, renal function, care level of
admission, and the Clinical Frailty Scale
&&Twenty-one observations were excluded due to having missing covariate data
&&&The four patients that were terminally ill (CFS=9) were not included due to the low number of cases
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health approaches must take into account a large num-
ber of patients with increased care needs and position
adequate resources to ensure robust supported discharge
schemes for those admitted to hospital. Frailty screening
should become a standard practice at admission in order
to identify patients early who are most likely to benefit
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